Low MHPG and continuing treatment in panic disorder.
1. The paper presents a naturalistic study of 3-Methoxy-4-hydroxyphenylglycol and treatment response in panic disorder. 2. Twenty-eight patients unmedicated for at least one month were entered in a study of MHPG in panic disorder, and given the option of continuing or not continuing treatment. 3. At baseline and on average follow-up 6.8 months later, patients continuing in treatment had significantly lower MHPG than those who did not. 4. At baseline, the two groups of patients did not differ significantly as to number of panic attacks, Zung anxiety scale, and Beck and Hamilton Depression scales. 5. Treated patients did better on all clinical measures at follow-up. 6. Low MHPG may be related to persistence in seeking treatment for panic disorder, and perhaps to treatment response.
Department of Psychiatry, R.I. Hospital, Providence.
M J
MJ
Edlund
A C
AC
Swann
D000328:Adult; D000367:Age Factors; D000525:Alprazolam / Q000627:therapeutic use; D005239:Fear; D005260:Female; D006018:Glycols / Q000097:blood*; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000097:blood* / Q000188:drug therapy / Q000628:therapy; D008734:Methoxyhydroxyphenylglycol / Q000097:blood*; D008875:Middle Aged; D010200:Panic; D011569:Psychiatric Status Rating Scales
D006018:Glycols; D008734:Methoxyhydroxyphenylglycol; D000525:Alprazolam